Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis C, Chronic 1 Carcinoma, Hepatocellular 1

Interventions

Radiotherapy 10 Cisplatin 10 Carboplatin 7 Capecitabine 6 Neoadjuvant Therapy 5 Gemcitabine 5 Fluorouracil 5 Docetaxel 5 Paclitaxel 4 Cyclophosphamide 4 Trastuzumab 3 Tamoxifen 3 Surgical Procedures, Operative 3 Radiation 3 Oxaliplatin 3 Hydralazine 3 Etoposide 3 Drug Therapy 3 pertuzumab 2 pegylated granulocyte colony-stimulating factor 2 palbociclib 2 endostar protein 2 Valproic Acid 2 Tranexamic Acid 2 Temozolomide 2 TP protocol 2 Saline Solution 2 Radiotherapy, Adjuvant 2 Proton Pump Inhibitors 2 Pemetrexed 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER_GOV × daclatasvir × Clear all

NCT02771405 2026-04-13

FRI-STC

National Hepatology & Tropical Medicine Research Institute

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡